ReviewInfection and drug resistance2019

Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C.

Lindsey M Childs-Kean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.